The latest closing stock price for Citius Oncology as of September 17, 2024 is 1.63.
An investor who bought $1,000 worth of Citius Oncology stock at the IPO in 2022 would have $-838 today, roughly -1 times their original investment - a -59.81% compound annual growth rate over 2 years.
The all-time high Citius Oncology stock closing price was 40.50 on August 07, 2024.
The Citius Oncology 52-week high stock price is 49.00, which is 2906.1% above the current share price.
The Citius Oncology 52-week low stock price is 1.53, which is 6.1% below the current share price.
The average Citius Oncology stock price for the last 52 weeks is 10.82.
An investor who bought $1,000 worth of Citius Oncology stock at the IPO in 2022 would have $-838 today, roughly -1 times their original investment - a -59.81% compound annual growth rate over 2 years.
The all-time high Citius Oncology stock closing price was 40.50 on August 07, 2024.
The Citius Oncology 52-week high stock price is 49.00, which is 2906.1% above the current share price.
The Citius Oncology 52-week low stock price is 1.53, which is 6.1% below the current share price.
The average Citius Oncology stock price for the last 52 weeks is 10.82.